Latest News
Private equity acquisitions surged in Japan last year, driven by long running structural trends. After a two-decade wait, a small group of US buyout firms are preparing for the next wave of domestic corporate carve-outs
International fundraising slumped in China last year as regulatory risk and geopolitical tensions scared away investors. Pan-Asian private equity funds are seeking out alternatives whether those investors return or not.
MidOcean Partners, a New York-based alternative asset manager specialising in middle-market private equity and alternative credit investments, has closed MidOcean Partners VI, with over $1.5 billion in capital commitments, making it MidOcean’s largest fund since inception.
RCP Advisors, a sponsor of private equity funds-of-funds, secondary funds, and co-investment funds focused on North American lower middle market buyouts, has held the final closing of RCP Fund XVII with approximately $328 million in aggregate commitments, exceeding its target of $300 million.
Quadrivio Group’s Industry 4.0 fund, a private equity vehicle investing in digital transition and technological innovation for Italian SMEs, is to sell EPI, an Italian company that specialises in the sale of sports merchandise for Serie A football clubs, to Fanatics, a global specialist in licensed sports merchandise with operations in over 60 countries.
The sale of EPI, which the Quadrivio Group acquired in November 2020, marks the first exit for Industry 4.0 Fund. During Quadrivio’s two and a half years of ownership, the company has significantly increased its sales by about 125% and more than doubled its profitability.
EPI
Growth equity firm General Atlantic has completed its acquisition of Iron Park Capital Partners, a global investment manager focused on public and private credit markets, to form General Atlantic Credit.
Cure Ventures, a life sciences venture capital firm focusing on company formation around curative technologies, has closed its inaugural fund, Cure Ventures Fund I, at its targeted hard-cap of $350 million in capital commitments.
Syncona Ltd, a healthcare investment company focused on the life sciences sector, has appointed Roel Bulthuis as managing partner and head of investments. Bulthuis has over 20 years of life science venture capital, business development and investment banking experience.
Bulthuis joins from Inkef Capital, an Amsterdam-based venture capital firm, where he held the position of managing partner and head of healthcare. Before this, he served as senior vice president and managing director of Merck Group’s M-Ventures for almost 10 years.
Prior to his time at M-Ventures, Bulthuis held senior positions in global business development at Merck Serono and was in
Ethos Capital has acquired Newforma, a collaboration platform aimed at helping companies deliver complex architectural, engineering, and construction projects more efficiently and cost-effectively.
KKR has held the final close of European Fund VI with $8.0 billion in capital commitments, making it the firm’s largest European Private Equity fund to date, surpassing the $6.6 billion KKR raised for its predecessor vehicle in 2019.
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
